Brain aneurysm patients: how does clopidogrel affect you?
NCT ID NCT05945563
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at 208 people with cerebral aneurysms who were treated with clopidogrel, a blood thinner. Researchers wanted to find out how many patients are overly sensitive to the drug and what happens to them. The goal is to better understand risks and improve care for these patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- clopidogrel
- What this could lead to
- If successful, this study could help doctors better understand how clopidogrel affects some patients with brain aneurysms, potentially leading to safer treatment plans.
- What could go wrong
- This is an observational registry study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL ANEURYSM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.